Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Income towards Parent Company: 2023-2024

Historic Income towards Parent Company for Artiva Biotherapeutics (ARTV) over the last 2 years, with Dec 2024 value amounting to -$65.4 million.

  • Artiva Biotherapeutics' Income towards Parent Company fell 41.30% to -$16.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$61.9 million, marking a year-over-year change of. This contributed to the annual value of -$65.4 million for FY2024, which is 127.62% down from last year.
  • As of FY2024, Artiva Biotherapeutics' Income towards Parent Company stood at -$65.4 million, which was down 127.62% from -$28.7 million recorded in FY2023.
  • Over the past 5 years, Artiva Biotherapeutics' Income towards Parent Company peaked at -$28.7 million during FY2023, and registered a low of -$65.4 million during FY2024.
  • Over the past 2 years, Artiva Biotherapeutics' median Income towards Parent Company value was -$47.0 million (recorded in 2023), while the average stood at -$47.0 million.
  • Data for Artiva Biotherapeutics' Income towards Parent Company shows a maximum YoY slumped of 127.62% (in 2024) over the last 5 years.
  • Artiva Biotherapeutics' Income towards Parent Company (Yearly) stood at -$28.7 million in 2023, then tumbled by 127.62% to -$65.4 million in 2024.